Dr. Meg Mooney helps coordinate cancer clinical trial networks across the country and internationally, and also organizes initiatives related to innovative cancer treatment reviews and precision medicine. In this episode, Mooney discusses a new natural history study the National Cancer Institute launched for cancer patients with COVID-19, as well as the work being done in drug discovery and development during this time.
HealthCast
Season 1
Episode 10
18m listen
Dr. Meg Mooney, Associate Director of CTEP, NCI
Share
The office coordinates nationwide testing of new treatment approaches for cancer.
-
Meg Mooney Associate Director of CTEP NCI
Related Content
-
USPIS Uses AI to Advance Criminal Investigations
The U.S. Postal Inspection Service is using AI to uncover crime patterns, support investigations and improve workforce efficiency.
5m watch -
Advice for the Next Generation of Cybersecurity Professionals
Author Agathe Merle discussed breaking barriers in cybersecurity, fostering inclusion and using creativity to strengthen cyber defense.
29m watch -
How Army Contracting Command is Using AI in Acquisition
Army Contracting Command’s Jordan Duke discusses AI adoption, cybersecurity risks and securing acquisition operations across the Army enterprise.
9m listen -
Treasury's Data Transparency Push Brings 250 Years of Federal Finance Into Focus
Justin Cole discusses Treasury's new data initiative, AI's role in public access, and why trusted government financial data remains essential.
10m listen
